Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1996-07-10
1998-06-23
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424400, 424465, 514841, 514843, A61K 920
Patent
active
057702268
ABSTRACT:
Disclosed are methods and compositions for oral contraception. Certain compositions of the invention contain androgens, preferably methyltestosterone to be taken by younger users of the contraceptives to inhibit adverse effects of oral contraceptive use on bone mineral density.
REFERENCES:
patent: 4220599 (1980-09-01), Van Der Vies
patent: 5211952 (1993-05-01), Spicer et al.
patent: 5340584 (1994-08-01), Spicer et al.
patent: 5595759 (1997-01-01), Wright et al.
The Contraception Report, Baylor College of Medicine, vol. VI, No. 5, Nov. 1995.
Adams, Kaplan and Williams, "Effects of androgens on coronary atherosclerosis and atherosclerosis-related impairment of vascular responsiveness," Arterioscler. Thromb. Vasc. Biol., 15:562-570, 1995/Feb.
Adashi, "The climacteric ovary as a functional gonadropin-driven androgen-producing gland," Fertil. Steril., 62:20-27, 1994/Jul.
Barrett-Connor, "The economic and human costs of osteoporotic fracture," Am. J. Med., 98(Suppl. 2A):3S-8S, 1995/Feb.
Bubenik, Schams and Coenen, "The effect of artificial photoperiodicity and antiandrogen treatment on the antler growth and plasma levels of LH, FSH, testosterone, prolactin and alkaline phosphatase in the male white-tailed deer," Comp. Biochem. Physiol A Comp. Physiol., 87:551-559, 1987.
Buchanan, Hospodar, Myers, Levenberger, and Demers, "Effects of excess endogenous androgens on bone density in young women," J. Clin. Endocrinol. Metab., 67:937-943, 1988/Feb.
Carr, Bresau, Givens, Byrd, Barnett-Hamm and Marshburn, "Oral contraceptive pills, gonadotropin-releasing hormone antagonists, or use in combination for treatment of hirsutism: A clinical research center study," J. Clin. Endocrin. Metab., 80:1169-1178, 1995.
Castro, Rose, Green, Lehner, Peterson and Taub, "Ketamine HCl as a suitable anesthetic for endocrine, metabolic, and cardiovascular studies in Macaca fascicularis monkeys," Proc. Soc. Exp. Biol. Med., 168:389-394, 1981.
Cauley, Gutai, Kuller, Scott and Nevitt, "Black-white differences in serum sex hormones and bone mineral density," Am. J. Epidemiol., 139:1035-1046, 1994, Feb.
Clarkson, Shively, Morgan, Koritnik, Adams and Kaplan, "Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys," Obstet. Gynecol., 75:217-222, 1990, Feb.
Colvard, Eriksen, Keeting, Wilson, Lubahn, French, Riggs and Spelsberg, "Identification of androgen receptors in normal human osteoblast-like cells," Proc. Natl. Acad. Sci. USA, 86:854-857, 1989, Feb.
DeCherney, "One-sparing properties of oral contraceptives", Am. J. Obstet. Gynecol., 174:1, 1993/Oct.
Duhper, Warren, Brooks-Gunn and Fox, "Effects of hormonal status on bone density in adolescent girls," J. Clin. Endocrinol. Metab., 71:1083-1088, 1990.
Enzelberger H, Metka M, Heytmanek G, Schurz B, Kurz B, Kusztrich M. Influence of oral contraceptive use on bone density in climacteric women. Maturitas 1988; 9:375-8.
Flanagan, Lea and Kendall, "Casodex reduces bone formation rate in female rats," (Abstract), J. Bone Miner. Res., 10(Suppl 1):S349, 1995.
Fortney J, Feldblum PJ, Talmage RV, Zhang. Bone mineral density and history of oral contraceptive use. J Reprod Med 1994; 39:105-9.
Frank, "The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton", Acta Paediatr., 84:627-630, 1995.
Gallagher et al., "Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in femal rats", American Physiological Society, 270:E407-412, 1996.
Gallagher et al., "Ovarian transplantation maintains bone formation more effectively than exogenous oestrogen in ovariectomised osteopenic rats", Department of Histopathology, St. George's Hospital Medical School, London. Jan. 1996.
Gambacciani, Spinetti, Taponeco, Cappagli, Piaggesi and Fioretti, "Longitudinal evaluation of perimenopausal vertebral bone loss: effects of low-dose oral contraceptive preparation on bone mineral density and metabolism," Obstet. Gynecol., 83:392-396, 1994.
Garnero et al., "Decreased bone turnover in oral contraceptive users", Bone, vol. 16:5, 499-503, 1995.
Garnero et al., "Genetic influence on bone turnover in postmenopausal twins", Journal of Clinical Endrocrinology and Metabolism, vol. 81:1, 140-146, 1996.
Goldsmith and Johnston, "Bone mineral: Effects of oral contraceptives, pregnancy, and lactation," J. Bone J. Surg., 57A:657-668, 1975.
Hickock, Toomey and Speroff, "A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women," Obstet. Gynecol., 82:919-924, 1993/Dec.
Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M. Association of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1988; 159:318-22.
Hughes, Wall, Phil and Creasman, "Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause," Gynecol. Oncol., 40:42-45, 1991.
Jayo, Jerome, Lees, Rankin and Weaver, "Bone mass in female cynomolgus macaques: A cross-sectional and longitudinal study by age," Calcif. Tissue Int., 54:231-6, 1994.
Jayo, Rankin, Weaver, Carlson and Clarkson, "Accuracy and precision of lumbar bone mineral content by dual-energy X-ray absorptiometry in live female monkeys," Calcif. Tissue Int., 49:438-440, 1991/Jan.
Jayo, Register, Carlson, Rankin, Siew and Sulistiawati, "Effects of thiazide and estrogen on bone in ovariectomized monkeys," (Abstract), J. Bone Miner. Res., 10:S256, 1995.
Jayo, Weaver, Adams and Rankin, "Anthropometry and bone mineral status in endocrinologically manipulated female cynomolgus macaques (Macaca fascicularis)," (Abstract), J. Bone Miner. Res., 4(Suppl 1):S181, 1989.
Jayo et al., "Effects on bone of surgical menopause and estrogen therapy with or without progesterone replacement in cynomolgus monkeys", Am. J. Obstet. Gynecol. 193:614-618, 1990.
Jerome, Carlson, Register, Bain, Jayo, Weaver and Adams, "Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry," J. Bone Miner. Res., 9:527-540, 1994.
Johnell O, Nilsson BE. "Life-style and bone mineral mass in perimenopausal women." Calcif Tissue Int (1984) 36:354-356/1984.
Kanders, Dempster and Lindsay, "Interaction of calcium nutrition and physical activity on bone mass in young women," J. Bone Miner. Res., 3:145-149, 1988.
Kanis, "Treatment of osteoporosis in elderly women," Am. J. Med., 98(Suppl. 2A):605-665, 1995/Feb.
Kasperk, Fitzsimmonds, Strong, Mohan, Jennings, Wegedal and Baylink, "Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone," J. Clin. Endocrinol. Metab., 71:1322-1329, 1990.
Kasra and Grynpas, "The effects of androgens on the mechanical properties of primate bone," Bone, 17:265-270, 1995.
Kelepouris et al., "Severe Osteoporosis in Men", Ann. Intern. Med., 123:452-460, 1995/Sep.
Kleerekoper M, Brienza RA, Schultz LR et al. Oral contraceptive use may protect against low bone mass. Arch Intern Med 1991: 151:1971-1976. Oct.
Kritz-Silverstein D, Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Amer J Public Health 1993; 83(1):100-102.
Lea et al., "Casodex (a nonsteroidal antiandrogen) reduces cancellous, Budosteal, and periosteal bone formation in estrogen replete femal rats", Calcif. Tissue Int., 58:268-272, 1996.
Lea, Moxham and Flanagan, "Androstenedione protects against cancellous bone loss in the ovariectomized rat," (Abstract), J. Bone Miner. Res., 10(Suppl. 1):S349, 1995.
Lindsay, Tohme and Kanders, "The effect of oral contraceptive use on vertebral bone mass in pre-and post-menopausal women," Contraception, 34:333-340, 1986.
Lloyd T, Buchanan JR, Urismo GR, Myers C, Woodward G, Halbert DR. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 1989; 160:402-404.
Matkovic, Jelic, Wardlaw, Ilich, Goel, Wright, Andon, Smith and Heaney, "Timing of peak bone mas
Hughes, Jr. Claude L.
Jayo Manuel J.
Page Thurman K.
Spear James M.
Wake Forest University
LandOfFree
Combined pharmaceutical estrogen-androgen-progestin oral contrac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined pharmaceutical estrogen-androgen-progestin oral contrac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined pharmaceutical estrogen-androgen-progestin oral contrac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1392610